Different histone post-translational modifications (PTMs) are crucial in the regulation of chromatin, including methylations of H3 at Lysine 4 by the MLL complex. A relevant issue is how this is causally correlated to the binding of specific transcription factors (TFs) in regulatory regions. NF-Y is a TF that regulates 30% of mammalian promoters containing the widespread CCAAT element. We and others established that the presence of H3K4me3 is dependent upon the binding of NF-Y. Here, we investigate the mechanisms of H3K4me3 deposition by NF-Y.
We employed Chromatin Immunoprecipitation in cells in which Ash2L and NF-Y subunits were knocked down by RNAi, to monitor the presence of histones PTMs and components of the MLL complex. We performed gene expression profiling of Ash2L-knocked down cells and analyzed the regulated genes. We performed ChIPs in leukemic cells in which MLL1 is devoid of the methyltransferase domain and fused to the AF4 gene.
Knock down of the Ash2L subunit of MLL leads to a decrease in global H3K4me3 with a concomitant increase in H3K79me2. Knock down of NF-Y subunits prevents promoter association of Ash2L, but not MLL1, nor WDR5, and H3K4me3 drops dramatically. Endogenous NF-Y and Ash2L specifically interact in vivo. Analysis of the promoters of Ash2L regulated genes, identified by transcriptional profiling, suggests that a handful TF binding sites are moderately enriched, among which the CCAAT box. Finally, leukemic cells carrying the MLL-AF4 translocation show a decrease of H3K4me3, absence of Ash2L and increase in H3K79me2, while NF-Y binding was not significantly affected.
Three types of conclusions are reached: (i) H3K4 methylation is not absolutely required for NF-Y promoter association. (ii) NF-Y acts upstream of H3K4me3 deposition by recruiting Ash2L. (iii) There is a general cross-talk between H3K4me3 and H3K79me2 which is independent from the presence of MLL oncogenic fusions.
Citation: Fossati A, Dolfini D, Donati G, Mantovani R (2011) NF-Y Recruits Ash2L to Impart H3K4 Trimethylation on CCAAT Promoters. PLoS ONE 6(3): e17220. https://doi.org/10.1371/journal.pone.0017220
Editor: Axel Imhof, Ludwig-Maximilians-Universität München, Germany
Received: September 1, 2010; Accepted: January 26, 2011; Published: March 21, 2011
Copyright: © 2011 Fossati et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) and Cassa di Risparmio delle Provincie Lombarde CARIPLO-Nobel grants to RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Histone post-translational modifications -PTMs- are marks of chromatin environments. Some of them are associated with accessible chromatin, others with heterochromatin, either constitutive or facultative . Specifically, monoubiquitination of H2B at Lysine 120 –K123 in yeast- is one of the earliest events in the establishment of an active chromatin environment . H3 methylations follow, on H3K4 and H3K79, in a hierarchy of events that leads to gene activation. Methylation of H3K4 is highly regulated  and generally present in active and poised promoters . The major H3K4 Methyltransferase is MLL (ALL1), the human homologue of the Drosophila Trithorax, assembled in a complex that includes Menin, Ash2L, WDR5, RbBP5, DPY30 and HCFs –. The 4 MLL genes in humans, MLL1-4 contain a Set domain which mono-, di- and tri-methylates H3K4 ; proteins within the complex are important to impart substrate specificity . Specifically, the complex is unable to tri-methylate H3K4 in the absence of Ash2L , . Moreover, MLL1 is involved in chromosomal translocations with a large cohort of >50 loci in aggressive myeloid and lymphoid leukemias .
In general, a key question is how histone modifying complexes are selectively and timely recruited to promoters, and binding of sequence-specific transcription factors offers a convenient explanation –. NF-Y is a trimer composed of NF-YA, NF-YB and NF-YC , which regulates the CCAAT box, one of the most frequent and crucial promoter elements . A connection between NF-Y binding and H3K4 methylations was initially noticed on the promoters of the ER-stress response genes, prior to induction , . This was confirmed in genome-wide correlative ChIP on chip studies, since NF-Y and H3K4me3 locations overlapped significantly and correlated with expression . In cause-effect experiments, we and others noticed a parallel decrease in NF-Y binding, H3K4me3, H3K79me2 and transcription using a dominant negative NF-YA mutant –. The reverse was not tested, namely whether H3K4me3 is important for NF-Y promoter association. This is a relevant point, since not all TFs are apparently equal in this regard: in a detailed correlative analysis, MYC binding was always associated with a specific context of histone marks, notably H3K4me3 and H3K79me2, but its removal –and comparison between myc+/+ and myc−/− cells- left the H3K4 pattern intact at target sites, whereas H4 acetylations were substantially ablated. Therefore, it was concluded that these marks are required for MYC binding to E boxes . In a previous study focusing on cell cycle regulated promoters in single nucleosome ChIP assays, we established that H3K4 di-methylation is unaffected by NF-Y binding, which is instead involved in the transition to mono- and tri-methylation upon gene activation. We then focused on H3K4me1: NF-Y promotes it by recruiting the CoREST-KDM1 H3K4me2 demethylase complex through contacts between NF-Y and CoREST . Here, we report studies on the deposition of the H3K4me3 mark on CCAAT promoters. In particular, we first tested the hypothesis that H3K4me3 might be generally helpful in NF-Y promoter association, by eliminating Ash2L, the one subunit of the complex that is specifically required for the deposition of this mark.
Knock down of Ash2L leads to decrease in H3K4me3, increase in H3K79me2 and selective reduction of NF-Y binding
To study the role of H3K4me3 in NF-Y promoter association, we knocked down Ash2L by siRNA in HCT116 cells: Figure 1A shows that a substantial reduction of Ash2L –down to 30% of normal levels- could be achieved, while other subunits of MLL complexes, Menin and WDR5, were, if anything, increased (Fig. 1A). Global levels of H3K4 methylations were controlled by Western blot analysis: H3K4me3 reduction by Ash2L siRNA was matched by an increase of H3K4me2, while H3K4me1 was unchanged (Fig. 1A, Lower Panels). Next, we performed ChIP experiments with chromatin of HCT116 cells treated with control and Ash2L siRNAs, using antibodies against NF-Y, H3K4me3, H3K4me2, H3K79me2 and Ash2L; we analyzed a few promoters that are representatives of the different classes of CCAAT promoters -housekeeping, cell cycle and ER-stress- as well as of promoters devoid a of the CCAAT box -CCAAT-less- serving as controls. In parallel, we analyzed the transcriptional profile of the genes considered. Fig. 1B shows a two to four-fold decrease of H3K4me3 on most promoters, with the exception of TICAM2 and ERP70. Interestingly, H3K79me2 levels were concomitantly increased (2 to 3-fold): indeed, the greater the loss of H3K4me3, the higher the increase of H3K79me2. NF-Y binding was decreased on some promoters -ERP70, CHOP, PCNA but not abolished. In most other promoters, however, the decrease in NF-Y binding was marginal. We conclude that the presence of H3K4me3 moderately influences NF-Y binding only on some promoters, and that indirect removal of H3K4me3 by inactivation of Ash2L leads to a compensatory positive effect on H3K79me2.
A. Knock down of Ash2L in HCT116 human cells. Western blot analysis of the indicated proteins and histone PTMs in cells transfected with scramble and Ash2L siRNAs. On the right, the levels of Ash2L protein inactivation, based on three independent experiments. B. In the upper Panel, mRNAs levels of the indicated genes in HCT116 cells transfected with scramble (Grey bars) or Ash2L siRNAs (Black bars) were assessed by qRT-PCR. In the lower Panels, Chromatin immunoprecipitation (ChIP) analysis was performed with the indicated antibodies (NF-YB, H3K4me2, H3K4me3, H3K79me2) in the same cells transfected with scramble or Ash2L siRNA. qPCR analysis was performed with primers centered in the core promoters of the indicated genes. CCAAT-less refers to genes with no CCAAT box in the promoters. Cell cycle and ER-stress are two categories of promoters with functionally important CCAAT boxes.
NF-Y recruits Ash2L on CCAAT-containing promoters
Removal of the NF-Y trimer from cell cycle promoters by an NF-YA dominant negative mutant led to a substantial decrease of H3K4 tri-methylation –, which is dependent from Ash2L, but not H3K4 di-methylation. One possibility is that NF-Y is important specifically for Ash2L recruitment. To establish this point, we decided to use an alternative system: knock down of the NF-YB (Fig. 2A) and of NF-YA (Fig. 2B) subunits in HCT116 cells by shRNA interference. Western blot analysis of NF-Y subunits confirmed the selective reduction of the respective NF-Y subunits: to 30% for NF-YB and 27% for NF-YA. Ash2L, as well as the global levels of H3K4me3 were not affected. ChIP assays on the NF-Y-dependent promoters analyzed in Fig. 1 showed a parallel reduction of NF-YB, H3K4me3 and Ash2L, whereas the presence of MLL1 and WDR5 was unaffected. On the control CCAAT-less UNG, COA5 and TICAM2 promoters, no NF-Y binding and robust Ash2L association was evident (Fig. 2A and 2B); MDM2, instead, showed a drop in Ash2L: a possible interpretation is that an important NF-Y site in a distant region impacts on promoter organization affecting H3K4me3.
A. Knock down of the NF-YB subunit in HCT116 human cells by infection with control (GFP) or NF-YB shRNA producing Lentiviruses. Left Panels: Western blot analysis of the indicated proteins and histone PTMs, with a statistical evaluation of the degree of NF-YB protein knock down, measured based on three independent experiments. Right Panels: in the upper Panel, mRNAs levels of the indicated genes in HCT116 cells transfected with control GFP (Grey bars), or NF-YB shRNAs (Black bars) assessed by qRT-PCR. In the lower Panels, Chromatin immunoprecipitation (ChIP) analysis was performed with the indicated antibodies (NF-YB, H3K4me3, Ash2L, MLL1, WDR5) in the same cells. qPCR analysis was performed with primers centered in the core promoters of the genes. The same set of promoters of Figure 1 were analyzed. B. Same as A, except that cells were knocked down with shRNA for NF-YA.
To ascertain whether there is a NF-Y-Ash2L interaction in vivo, we performed immunoprecipitations with NF-Y and Ash2L antibodies with HCT116 nuclear extracts, followed by Western blot analysis. Fig. 3 shows that Ash2L is immunoprecipitated with anti-NF-YB antibodies, whereas minimal levels of Menin and WDR5 were present in the bound fraction. The reciprocal was also true, as substantial amounts of NF-YA was in the Ash2L IP. Control IPs were negative for all proteins tested. Taken together, these data indicate that the recruitment of Ash2L is dependent upon NF-Y binding, that there is a NF-Y-Ash2L interaction in vivo, and that other subunits of the MLL complex are recruited independently from Ash2L.
Western blot analysis of immunprecipitations with anti-NF-YB (Left Panel) and anti-Ash2L (Right Panel) antibodies, using acid-extracted nuclear extracts of HCT116 cells. Control IPs with anti-Flag antibodies were run in parallel. The Load lane refers to the starting nuclear extract material. Menin and WDR5 were marginally immunoprcipitated with anti-NF-YB, whereas Ash2L recovery was robust. The heavy (IgH) and light (IgL) chains of the IP antibodies are indicated.
To ascertain whether Ash2L is recruited preferentially on CCAAT promoters, we performed expression profiling of HCT116 cells after knock down of Ash2L by siRNA, with the protocol shown above in Fig. 1. By setting the threshold at 1.35, 477 genes were down-regulated and 175 up-regulated (Fig. S1). We validated by qRT-PCR 32 of these genes, and the adherence to the gene expression data was almost complete (Fig. 4A). The overall greater changes observed by qRT-PCR analysis suggest that additional genes below the threshold considered are affected by Ash2L interference. Analysis of Gene Ontology terms indicates that Ash2L targets different classes of genes, with DNA and RNA Metabolism being dominant in the Biological Process and Molecular Function categories (Fig. 4B). We then analyzed the regulated promoters to identify enriched Transcription Factor Binding Site -TFBS- (Figure S2): CCAAT was indeed at a top of a short list of sites, together with a few other, but the p values were relatively modest, an indication that there is no strong skewing toward a specific TFBS. We conclude that Ash2L recruitment on CCAAT promoters is NF-Y-dependent, but that the function of this MLL subunit is not restricted to CCAAT promoters.
A. Validation of the profiling data for selected genes whose expression was activated or repressed by Ash2L inactivation, as in the experiments shown in Figure 1, was performed by qRT-PCR. B. Gene Ontology analysis of the profiling experiments of Ash2L-dependent genes.
Ash2L promoters association is affected in Mixed Lineage Leukemia cells
The results shown above indicate that NF-Y lies upstream of Ash2L recruitment and H3K4me3 deposition. Previous data on cell cycle genes indicate that H3K4me2 is present independently from NF-Y, raising the possibility that this mark is actually required for NF-Y recruitment. To further evaluate this point, we used the cell line RS4-11, derived from a Mixed Lineage Leukemia, which contains a rearrangement of the MLL1 gene with AF4: as in other MLL1 fusions, it lacks the SET domain and it is therefore devoid of H3K4 methylating activity (10). Note that in MLL-AF10 regulated genes, this is compensated by higher levels of H3K79me2 –, which is also under the control of NF-Y , . Therefore, we first evaluated the global levels of the proteins and histone PTMs considered in this study in RS4-11, showing that they were largely similar to what is found in REH, a control leukemia cell line that harbours normal MLL1 alleles (Fig. 5A). We then analyzed by ChIPs NF-Y, Ash2L and H3K4 methylations on CCAAT promoters, in RS4-11 and REH. The levels of H3K4me3 were lower in RS4-11 compared to REH on most, but not all promoters (Fig. 5B). Higher levels of H3K79me2 were found, specifically in the promoters with low levels H3K4me3, which is consistent with previous results with MLL-AF10 fusions –. The H3K4me1 and H3K4me2 levels were extremely low in RS4-11, with the exception of CKS2 and Cyclin B1 promoters. Importantly, the recovery of Ash2L were minimal from all promoters, while NF-Y binding was comparable in the two cell lines, including in promoters with residual levels of H3K4 methylations. We take this as a further indication that H3K4 methylations are not strictly required for NF-Y association. In addition, it is clear that the presence of the oncogenic fusion protein affects the levels of H3K4 mono-, di- and tri-methylation.
A. Western blot analysis of the levels of the indicated proteins (Ash2L, NF-Y subunits, global H3, H3K4me1, H3K4me2, H3K4me3, H3K79me2, and the internal control Vinculin) in MLL1-AF4 rearranged cells RS4-11 and in non MLL1 rearranged REH leukemic cells. B. In the upper Panel, mRNAs levels of the indicated genes in REH (Black bars) and RS4-11 (Grey bars) assessed by qRT-PCR. In the lower Panels, Chromatin immunoprecipitation (ChIP) analysis was performed with the indicated antibodies (NF-YB, Ash2L, H3K4mei, H3K4me2, H3K4me3, H3K79me2) in the same cells. qPCR analysis was performed with primers centered in the core promoters of the genes. The same set of promoters of Figure 1 were analyzed.
NF-Y and H3K4 methylations
A relevant question in chromatin studies is what determines the location of histone marks on genomes. The binding of TFs and cofactors to promoters are hallmarks of expression, by signalling to the Pol II machinery the appropriate positional coordinates. In general, it seems plausible that TFs are instrumental in determining the positions of specific histone PTMs. However, it is becoming increasingly clear that certain TFs do require a particular set of histone TFs to access regulatory regions: MYC binding, for example, happens only in sites in which H3K4 and H3K79 methylations are abundant . Hence, there must be a hierarchy in TF in establishing a certain chromatin environment, with some TFs being capable to recruit histone modifying enzymes for the benefit of additional TFs. There is a strong correlation in genomic locations of NF-Y and H3K4me3, and removal of NF-Y reduced the local, but not the global levels of H3K4me3 -. Unlike other TFs, the presence of high levels of H3K4me3 is not strictly required for NF-Y recruitment: indeed, NF-Y is involved in the recruitment of Ash2L, indicating that it acts upstream of H3K4me3, and placing it at the heart of the local di- to tri-methylation transition. Furthermore, the results in MLL cells, in which most promoters we analyzed have residual levels of any H3K4 methylation, yet robust NF-Y association, indicate that none of the methylations of H3K4 is strictly required for binding of the trimer to DNA. The fact that H3K4 methylations are downstream of H2B monoubiquitination ( and References therein] renders the H2B-like structure of NF-YB particularly relevant, since a parallel signalling can be envisaged.
The presence of the CCAAT box at the top of the list of the Ash2L regulated genes, together with few other TFBS with similar scores, is in line with the data. However, the relatively low statistical enrichments in TFBS analysis among Ash2L-regulated promoters indicate that the preference is not absolute, and many other TFs can recruit Ash2L, as indicated by genetic screenings for interactors of AP2, Mef2c, PAX7 and Tbx1 –. We confirm that removal of Ash2L leads to a drastic decrease in the global levels of H3K4me3, while H3K4me2 and H3K4me1 are not substantially changed. Whether Ash2L is the only subunit of the complex to direct the MLL activity toward trimethylation is currently unclear . As Ash2L is believed to be present in complexes containing different MLLs, we were surprised by the relatively low number of genes affected by Ash2L interference. There are technical explanations for this, such as the incomplete elimination of the protein and the fact that hybridization-derived profiling data are less sensitive to variation with respect to qRT-PCR, suggesting that many additional genes were indeed missed. In addition, the presence of partially redundant activities similar to Ash2L, such as Ash1 , should be considered.
Reciprocal regulation of H3K4me3 and H3K79me2
MLL is a complex and genetically heterogeneous disease in which MLL1 fusion proteins alter gene expression; this is, in part, due to the partners, some of which -AF4, AF9 and ENL- have transcription activation domains required for transformation , . In cells bearing AF10 fusions, reduced H3K4me3 was reported to be “compensated” by high H3K79me2 levels. AF10 was shown to bind to hDOT1L, through a domain required for transformation . In accordance with these data, in our analysis of leukemic cells with an MLL1-AF4 fusion, the H3K4me3 decrease is also “compensated” by an increase in H3K79me2. However, in HCT116 cells, which carry a wt MLL1 configuration, the removal of Ash2L alone, by decreasing H3K4me3, is sufficient to increase H3K79me2, and there is an inverse correlation between these two marks on each of the promoters we analyzed. One could therefore hypothesize that it is the absence of Ash2L on promoters, rather than, or in addition to an AF4 or AF10-mediated recruitment of hDOT1L, which leads to high H3K79me2 levels. This finding could have consequences in the temporal deposition of the two marks, which lie downstream of H2BUb, suggesting that H3K79me2 acts upstream of H3K4me3. This matter is further complicated by the fact that mono- and di-methylations are also dramatically affected in MLL cells, which was somewhat expected, based on the assumption that the SET domain is absent from the MLL fusions, but never tested. Importantly, in the absence of the N-terminal end of MLL1, Ash2L is not recruited onto promoters. These data indicate that the oncogenic potential might be influenced by the variation of composition of the MLL complex as a whole, as well as by the presence of the fusion partner.
A link between the MLL complex and NF-Y in cellular transformation?
In 23 acute lymphoblastic leukemias with MLL translocations, two signatures correlating with prognosis were found . Top rank genes were HspCBF, an NF-Y coactivator  in the poor prognosis group, and CDP, a negative regulator of CCAAT activity , in the cohort with good prognosis. Importantly, genes with two CCAAT boxes, predicted to be down-regulated by CDP, were found underexpressed in the latter group. (ii) The CCAAT box was repeatedly reported, along with E2F sites, in genes specifically overexpressed in tumors –. Notably, de novo motifs discovery in leukemias pointed at three sites: the expected E2F-NF-Y duo and p53 . (iii) Analysis of gene expression profiles of MLL-AF9 leukemias identified a haematopoietic stem cell -HSCs- signature that confers self-renewal properties , with some targets, such as HOXA members, important for tumor growth. Interestingly, NF-Y was shown to be a potent HSC self-renewal regulator, by activating HOX4 paralogues . Notably, the short form of NF-YA appears to be crucial , . Thus, MLL fusions and NF-Y could work together in reactivation of a self-renewal program. The absence of significant levels of H3K4 methylations is coupled to high levels of H3K79me2, a mark also dependent from the presence of NF-Y : we can imagine that NF-Y is also involved in the recruitment of the hDOT1 complex, even without the presence of the AF4/AF10 fusion partner. NF-Y-mediated recruitment of MLL complexes with an altered composition on growth-promoting genes could impair profoundly regulation, via alteration of the local histone PTMs. Further biochemical and in vivo ChIP work is required to shed light on this hypothesis.
Materials and Methods
Cell cultures and transfections
HCT116 cells were cultured in DMEM supplemented with 10% FCS, 1% penicillin and streptomycin, and L-glutamine. All transfections were carried out using Lipofectamine 2000 (Invitrogen, USA). The Ash2L siRNA was purchased by (Dharmacon, USA). Scrambled siRNA was used as a negative control (Ambion, USA). NF-YA and NF-YB shRNA vectors were purchased from Sigma; the control was a similar vector expressing shRNA against GFP.
RT-PCR analysis, Nuclear and Acid extracts preparation and Western blot analysis
Total RNAs were extracted using an RNA-Easy kit (Qiagen, D). 1µg of each RNA was retrotranscribed (Promega, USA). Normalization of the cDNAs were performed with GAPDH control. The RT-PCR primers used are listed in Figure S3.
Nuclear extracts were prepared according to standard procedures (20). Acid extracts were prepared collecting cells in 5–10 volumes of Lysis Buffer H (10 mM Hepes pH 7.9, 150 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 1.5 mM PMSF); Perchloric acid 0.2 M was added and cells were kept on ice for 30 minutes, followed by centrifugation for 10 minutes at 11000 g at 4°C; the supernatants were stocked at −80°C. 15 µg of nuclear and acid extracts were used in 12% SDS-PAGE. Proteins were transferred to nitrocellulose membranes and immunoblotted using the antibodies of interest. The protein-antibody complexes were detected using horseradish peroxidase-conjugated secondary antibodies (GE Healthcare, UK) and the chemioluminescence system (Genespin, I).
ChIP assays were performed as previously described (Donati et al, 2007). Immunoprecipitations were performed with ProtG-Sepharose (KPL, USA) and 3µg of the following antibodies: NF-YB (Genespin, I); H3 (Abcam 1791); H4K4me3 (Abcam 8580, Active Motif 39159); H4K4me2 (Abcam 7766); H4K4me1 (Abcam 8895); H3K79me2 (Abcam 3594), Ash2L (Active Motif 39099). The MLL antibody was a kind gift of E. Canaani (Weizman I., Il). The ChIP-PCR primers are listed in Figure S3. Quantitative Real Time PCR was performed using SYBR green IQ reagent (Biorad, USA) in the iCycler IQ. The relative sample enrichment was calculated with the following formula: 2 ΔCtx -2 ΔCtb, where ΔCt x = Ct input-Ct sample and ΔCt b = Ct input-Ct control Ab.
List of Ash2L-regulated genes in HCT116 cells. Genes whose expression is altered upon Ash2L knock down.
Transcription Factor Binding Site (TFBS) analysis of the promoters (-500/+100 from the Transcriptional Start Site) of the Ash2L-regulated genes derived from the profiling experiments.
List of primers used in q-RT-PCR and ChIPs.
We thank E. Canaani (Weizman I., Il), G. Cazzaniga, A. Biondi (F. Tettamanti, I) for gift of MLL reagents and cell lines, C. Imbriano (U. of Modena, I) for gift of shRNA vectors.
Conceived and designed the experiments: RM. Performed the experiments: AF GD. Analyzed the data: DD RM. Contributed reagents/materials/analysis tools: RM GD RM. Wrote the paper: RM.
- 1. Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447: 407–412.SL Berger2007The complex language of chromatin regulation during transcription.Nature447407412
- 2. Nakanishi S, Lee JS, Gardner KE, Gardner JM, Takahashi YH, et al. (2009) Histone H2BK123 monoubiquitination is the critical determinant for H3K4 and H3K79 trimethylation by COMPASS and Dot1. J Cell Biol 186: 371–317.S. NakanishiJS LeeKE GardnerJM GardnerYH Takahashi2009Histone H2BK123 monoubiquitination is the critical determinant for H3K4 and H3K79 trimethylation by COMPASS and Dot1.J Cell Biol186371317
- 3. Ruthenburg AJ, Allis CD, Wysocka , J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25: 15–30.AJ RuthenburgCD AllisWysockaJ2007Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark.Mol Cell251530
- 4. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823–837.A. BarskiS. CuddapahK. CuiTY RohDE Schones2007High-resolution profiling of histone methylations in the human genome.Cell129823837
- 5. Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, et al. (2002) ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 10: 1119–1128.T. NakamuraT. MoriS. TadaW. KrajewskiT. Rozovskaia2002ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.Mol Cell1011191128
- 6. Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, et al. (2006) Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 13: 713–9.Y. DouTA MilneAJ RuthenburgS. LeeJW Lee2006Regulation of MLL1 H3K4 methyltransferase activity by its core components.Nat Struct Mol Biol137139
- 7. Steward MM, Lee JS, O'Donovan A, Wyatt M, Bernstein BE, et al. (2006) Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol 13: 852–854.MM StewardJS LeeA. O'DonovanM. WyattBE Bernstein2006Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes.Nat Struct Mol Biol13852854
- 8. Wang P, Lin C, Smith ER, Guo H, Sanderson BW, et al. (2009) Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol Cell Biol 29: 6074–6085.P. WangC. LinER SmithH. GuoBW Sanderson2009Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II.Mol Cell Biol2960746085
- 9. Patel A, Dharmarajan V, Vought VE, Cosgrove MS (2009) On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex. J Biol Chem 284: 24242–4256.A. PatelV. DharmarajanVE VoughtMS Cosgrove2009On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex.J Biol Chem284242424256
- 10. Krivtsov AV, Armstrong SA (2007) MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer 7: 823–833.AV KrivtsovSA Armstrong2007MLL translocations, histone modifications and leukaemia stem-cell development.Nat Rev Cancer7823833
- 11. Wynder C, Hakimi MA, Epstein JA, Shilatifard A, Shiekhattar R (2005) Recruitment of MLL by HMG-domain protein iBRAF promotes neural differentiation. Nat Cell Biol 7: 1113–1117.C. WynderMA HakimiJA EpsteinA. ShilatifardR. Shiekhattar2005Recruitment of MLL by HMG-domain protein iBRAF promotes neural differentiation.Nat Cell Biol711131117
- 12. Dreijerink KM, Mulder KW, Winkler GS, Höppener JW, Lips CJ, et al. (2006) Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res 66: 4929–4935.KM DreijerinkKW MulderGS WinklerJW HöppenerCJ Lips2006Menin links estrogen receptor activation to histone H3K4 trimethylation.Cancer Res6649294935
- 13. McKinnell IW, Ishibashi J, Le Grand F, Punch VG, Addicks GC, et al. (2008) Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat Cell Biol 10: 77–84.IW McKinnellJ. IshibashiF. Le GrandVG PunchGC Addicks2008Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex.Nat Cell Biol107784
- 14. Rampalli S, Li L, Mak E, Ge K, Brand M, et al. (2007) p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 14: 1150–1156.S. RampalliL. LiE. MakK. GeM. Brand2007p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation.Nat Struct Mol Biol1411501156
- 15. Tan CC, Walsh MJ, Gelb BD (2009) Fgfr3 is a transcriptional target of Ap2delta and Ash2l-containing histone methyltransferase complexes. PLoS One 4: e8535.CC TanMJ WalshBD Gelb2009Fgfr3 is a transcriptional target of Ap2delta and Ash2l-containing histone methyltransferase complexes.PLoS One4e8535
- 16. Stoller JZ, Huang L, Tan CC, Huang F, Zhou DD, et al. (2010) AshL interacts with Tbx1 and is required during early embryogenesis. Exp Biol Med 235: 569–576.JZ StollerL. HuangCC TanF. HuangDD Zhou2010AshL interacts with Tbx1 and is required during early embryogenesis.Exp Biol Med235569576
- 17. Romier C, Cocchiarella F, Mantovani R, Moras D (2003) The crystal structure of the NF-YB/NF-YC heterodimer gives insight into transcription regulation and DNA binding and bending by transcription factor NF-Y. J Biol Chem 278: 1336–1345.C. RomierF. CocchiarellaR. MantovaniD. Moras2003The crystal structure of the NF-YB/NF-YC heterodimer gives insight into transcription regulation and DNA binding and bending by transcription factor NF-Y.J Biol Chem27813361345
- 18. Dolfini D, Zambelli F, Pavesi G, Mantovani R (2009) A perspective of promoter architecture from the CCAAT box. Cell Cycle 8: 4127–4237.D. DolfiniF. ZambelliG. PavesiR. Mantovani 2009A perspective of promoter architecture from the CCAAT box.Cell Cycle841274237
- 19. Baumeister P, Luo S, Skarnes WC, Sui G, Seto E, et al. (2005) Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol Cell Biol 25: 4529–40.P. BaumeisterS. LuoWC SkarnesG. SuiE. Seto2005Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers.Mol Cell Biol25452940
- 20. Donati G, Imbriano C, Mantovani R (2006) Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters. Nucleic Acids Res 34, 3116-3127: G. DonatiC. ImbrianoR. Mantovani2006Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters.Nucleic Acids Res 34,3116-3127
- 21. Ceribelli M, Dolfini D, Merico D, Gatta R, Viganò MA, et al. (2008) The histone like NF-Y is a bifunctional transcription factor. Mol Cell Biol 28: 2047–2058.M. CeribelliD. DolfiniD. MericoR. GattaMA Viganò2008The histone like NF-Y is a bifunctional transcription factor.Mol Cell Biol2820472058
- 22. Donati G, Gatta R, Dolfini D, Fossati A, Ceribelli M, et al. (2008) An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promoters. PLoS ONE 3: e2066.G. DonatiR. GattaD. DolfiniA. FossatiM. Ceribelli2008An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promoters.PLoS ONE3e2066
- 23. Gurtner A, Fuschi P, Magi F, Colussi C, Gaetano C, et al. (2008) NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissue. PLoS One 3: e2047.A. GurtnerP. FuschiF. MagiC. ColussiC. Gaetano2008NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissue.PLoS One3e2047
- 24. Gatta R, Mantovani R (2008) NF-Y substitutes H2A-H2B on active cell cycle promoters: recruitment of CoRest-KDM1 and fine tuning of H3 methylations. Nucleic Acids Res 36: 6592–6607.R. GattaR. Mantovani2008NF-Y substitutes H2A-H2B on active cell cycle promoters: recruitment of CoRest-KDM1 and fine tuning of H3 methylations.Nucleic Acids Res3665926607
- 25. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni , et al. (2006) Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8: 764–770.E. GuccioneF. MartinatoG. FinocchiaroL. LuziTizzoni2006Myc-binding-site recognition in the human genome is determined by chromatin context.Nat Cell Biol8764770
- 26. Neff T, Armstrong SA (2009) Chromatin maps, histone modifications and leukemia. Leukemia 23: 1243–51.T. NeffSA Armstrong2009Chromatin maps, histone modifications and leukemia.Leukemia23124351
- 27. Krivtsov AV, Feng Z, Lemieux ME, Faber J, Vempati S, et al. (2008) H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 14: 355–368.AV KrivtsovZ. FengME LemieuxJ. FaberS. Vempati2008H3K79 methylation profiles define murine and human MLL-AF4 leukemias.Cancer Cell14355368
- 28. Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, et al. (2005) hDOT1L links histone methylation to leukemogenesis. Cell 121: 167–178.Y. OkadaQ. FengY. LinQ. JiangY. Li2005hDOT1L links histone methylation to leukemogenesis.Cell121167178
- 29. Gregory GD, Vakoc CR, Rozovskaia T, Zheng X, Patel S, et al. (2007) Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes. Mol Cell Biol 27: 8466–79.GD GregoryCR VakocT. RozovskaiaX. ZhengS. Patel2007Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes.Mol Cell Biol27846679
- 30. Tsutsumi S, Taketani T, Nishimura K, Ge X, Taki T, et al. (2003) Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements. Cancer Res 63: 4882–4887.S. TsutsumiT. TaketaniK. NishimuraX. GeT. Taki2003Two distinct gene expression signatures in pediatric acute lymphoblastic leukemia with MLL rearrangements.Cancer Res6348824887
- 31. Imbriano C, Bolognese F, Gurtner A, Piaggio G, Mantovani R (2001) HSP-CBF is an NF-Y-dependent coactivator of heat shock promoters CCAAT boxes. J Biol Chem 276: 26332–26339.C. ImbrianoF. BologneseA. GurtnerG. PiaggioR. Mantovani2001HSP-CBF is an NF-Y-dependent coactivator of heat shock promoters CCAAT boxes.J Biol Chem2762633226339
- 32. Sansregret L, Nepveu A (2008) The multiple roles of CUX1: insights from mouse models and cell-based assays. Gene 412: 84–94.L. SansregretA. Nepveu2008The multiple roles of CUX1: insights from mouse models and cell-based assays.Gene4128494
- 33. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, et al. (2005) Mining for regulatory programs in the cancer transcriptome. Nat Genet 37: 579–83.DR RhodesS. Kalyana-SundaramV. MahavisnoTR BarretteD. Ghosh2005Mining for regulatory programs in the cancer transcriptome.Nat Genet3757983
- 34. Tabach Y, Milyavsky M, Shats I, Brosh R, Zuk O, et al. (2005) e promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation. Mol Syst Biol 1: 2005.0022.Y. TabachM. MilyavskyI. ShatsR. BroshO. Zuk2005e promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformation.Mol Syst Biol12005.0022
- 35. Sinha S, Adler AS, Field Y, Chang HY, Segal E (2008) Systematic functional characterization of cis-regulatory motifs in human core promoters. Genome Res 18: 477–488.S. SinhaAS AdlerY. FieldHY ChangE. Segal2008Systematic functional characterization of cis-regulatory motifs in human core promoters.Genome Res18477488
- 36. Goodarzi H, Elemento O, Tavazoie S (2009) Revealing global regulatory perturbations across human cancers. Mol Cell 36: 900–911.H. GoodarziO. ElementoS. Tavazoie2009Revealing global regulatory perturbations across human cancers.Mol Cell36900911
- 37. Zhu J, Zhang Y, Joe GJ, Pompetti R, Emerson SG (2005) NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal. Proc Natl Acad Sci USA 102: 11728–11733.J. ZhuY. ZhangGJ JoeR. PompettiSG Emerson2005NF-Ya activates multiple hematopoietic stem cell (HSC) regulatory genes and promotes HSC self-renewal.Proc Natl Acad Sci USA1021172811733
- 38. van Wageningen S, Nikoloski G, Vierwinden G, Knops R, van der Reijden BA, et al. (2008) The transcription factor nuclear factor Y regulates the proliferation of myeloid progenitor cells. Haematologica 93: 1580–1582.S. van WageningenG. NikoloskiG. VierwindenR. KnopsBA van der Reijden2008The transcription factor nuclear factor Y regulates the proliferation of myeloid progenitor cells.Haematologica9315801582
- 39. Domashenko AD, Danet-Desnoyers G, Aron A, Carroll MP, Emerson SG (2010) TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells. Blood, in press. AD DomashenkoG. Danet-DesnoyersA. AronMP CarrollSG Emerson2010TAT-mediated transduction of NF-Ya peptide induces the ex vivo proliferation and engraftment potential of human hematopoietic progenitor cells.Blood, in press